Sight sciences, inc. SGHT.US Overview
SGHT AI Analysis & Strategy
Browsing restrictions can be lifted for a fee.
SGHT Current Performance
-9.73%
Sight sciences, inc.
-1.83%
Avg of Sector
-0.40%
S&P500
SGHT Key Information
SGHT Revenue by Segments
Browsing restrictions can be lifted for a fee.
SGHT Net Income
Browsing restrictions can be lifted for a fee.
SGHT Cash Flow
Browsing restrictions can be lifted for a fee.
SGHT Profit Margin
Browsing restrictions can be lifted for a fee.
SGHT PE Ratio River
Browsing restrictions can be lifted for a fee.
SGHT Financial Forecast
Browsing restrictions can be lifted for a fee.
SGHT Earnings Table
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | |||||||
| 2024Q4 | |||||||
| 2024Q3 | |||||||
| 2024Q2 | |||||||
| 2024Q1 |
SGHT Profile
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
Price of SGHT
SGHT FAQ
When is SGHT's latest earnings report released?
The most recent financial report for Sight sciences, inc. (SGHT) covers the period of 2025Q1 and was published on 2025/03/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating SGHT's short-term business performance and financial health. For the latest updates on SGHT's earnings releases, visit this page regularly.
What is the operating profit of SGHT?
According to the latest financial report, Sight sciences, inc. (SGHT) reported an Operating Profit of -13.86M with an Operating Margin of -79.16% this period, representing a growth of 5.87% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is SGHT's revenue growth?
In the latest financial report, Sight sciences, inc. (SGHT) announced revenue of 17.51M, with a Year-Over-Year growth rate of -9.12%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much cash does SGHT have?
At the end of the period, Sight sciences, inc. (SGHT) held Total Cash and Cash Equivalents of 108.77M, accounting for 0.84 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does SGHT go with three margins increasing?
In the latest report, Sight sciences, inc. (SGHT) did not achieve the “three margins increasing” benchmark, with a gross margin of 86.2%%, operating margin of -79.16%%, and net margin of -80.8%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess SGHT's profit trajectory and future growth potential.
Is SGHT's EPS continuing to grow?
According to the past four quarterly reports, Sight sciences, inc. (SGHT)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.28. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
What is the FCF of SGHT?
Sight sciences, inc. (SGHT)'s Free Cash Flow (FCF) for the period is -11.61M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 17.19% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
What are the PEG ratio and PE ratio of SGHT?
The latest valuation data shows Sight sciences, inc. (SGHT) has a Price-To-Earnings (PE) ratio of -3.17 and a Price/Earnings-To-Growth (PEG) ratio of -0.13. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.